ClinicalTrials.gg
WithdrawnNCT05934500CBDSUpdated Sep 25, 2026

CBD Knee Scope Study

An Early Phase 1 interventional study of Cannabidiol Oil in Post-operative Pain, sponsored by Foundation for Orthopaedic Research and Education. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Foundation for Orthopaedic Research and Education · Early Phase 1, Interventional, and Treatment

How we know

Why this study was withdrawn
insufficient drug supply at the time.
Updated Sep 25, 2026Now WithdrawnEnrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Early Phase 1
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,181 studies in Pain, Postoperative with a site in United States — 204 open to participants now, 237 under way, 25 of them phase 3. Pain, Postoperative · United States.

Enrollment
1,023rd of 1,099
0 · median 76
Started
2023
with 54 others
Phase 1
49 of 1,181
9 open now
Registered
972nd of 1,181
by date

Among the 1,181 studies in Pain, Postoperative with a site in United States, this one is the 1,023rd largest by enrollment of the 1,099 interventional ones that give a count, is one of 55 that started in 2023, is one of 49 in phase 1, and was the 972nd registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

204 of the 1,181 studies in Pain, Postoperative with a site in United States are open now. Recruiting first, the newest first:

199 more — sign in →

All 204 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,181 studies in Pain, Postoperative with a site in United States, or all of them as a file.
02

Study summary

This is a prospective, randomized, nonblinded trial to evaluate the effectiveness of Cannabidiol (CBD) oil on post-operative pain control compared to opioid medications after a knee arthroscopy.

Read the detailed description

This is a prospective non-blinded randomized controlled trial with 3 groups of subjects all undergoing knee arthroscopy for soft tissue pathology. The first group will receive the SOC opioid course: 7 days of Percocet (oxycodone 5mg-acetaminophen 325mg) every four hours PO PRN, following surgery. the second 100 mg CBD daily for 30 days pre-operatively continuing 30 days post-operatively, and the third group 200 mg CBD daily for 30 days pre-operatively continuing 30 days post-operatively.

All subjects in each of the three groups will undergo standard pre-operative and post-operative care, including physical exams, imaging, and education. They will only differ in pre-operative pain medication administration if they are in one of the two CBD groups. The groups will undergo surveys (sleep quality, self-reported pain, need for refill or switch to opioids). Sleep quality will be assessed with the Insomnia Severity Index (ISI) while pain, need for refill, and switch to opioids will be recorded by the patient on CRF packets. The CRF packets will be given to patients at each visit for them to fill out to the best of their ability.

03

Conditions studied

  • Post-operative Pain

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or older
  • requiring knee arthroscopy for soft tissue injury, acute or chronic knee injury
  • able to complete surveys and follow-up visits

Exclusion criteria

Exclusion Criteria:

  • younger than 18 years of age
  • history of knee dislocation, fracture, previous surgery, coexisting extremity pathology, *pregnancy.
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Standard of Care

    Opioid standard of care: Percocet (oxycodone 5mg-acetaminophen 325 mg) every 4 hours PRN postoperatively for 7 days

  • Experimental
    Cannabidiol Oil 100 mg/day

    CDB 100mg PO liquid suspension QD starting 30 days prior to surgery and finishing 30 days post-operatively

    Drug: Cannabidiol Oil

  • Experimental
    Cannabidiol Oil 200 mg/day

    CBD 200mg PO liquid suspension QD starting 30 days prior to surgery and finishing 30 days post-operatively.

    Drug: Cannabidiol Oil

Interventions

06

What researchers measure

Primary outcomes

  1. Post-operative pain control

    Numerical Pain Scale (NRS) 0 being no pain, 10 being the worst pain imaginable.

    Time frame: 30 days post-operatively

Secondary outcomes

  1. Sleep Quality

    Insomnia Severity Index .

    Time frame: 30 days preoperatively leading up to surgery, then 30 days postoperatively. Outcomes will be collected from surgery to 6 weeks postoperatively.

07

Study locations

1 site
  • Foundation for Orthopaedic Research and Education/ Florida Orthpaedic Institute
    Tampa, Florida 33637, United States
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2023; primary completion for Jul 2025, 21 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2023
First posted
Jul 7, 2023
StartEst.
Oct 15, 2023
Primary completionEst.
Jul 15, 2025
CompletionEst.
Dec 30, 2025
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Withdrawn insufficient drug supply at the time.
changed Sep 25, 2026
Enrollment
100 (estimated)→0 (actual)
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Not yet recruiting→Withdrawn
    Why stopped insufficient drug supply at the time.
    Enrollment 100 (estimated)→0 (actual)
    + 3 other changes: verification date, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05934500
Lead sponsor
Foundation for Orthopaedic Research and Education
Responsible party
Sponsor
First posted
Jul 7, 2023
Start date
Oct 15, 2023 (estimated)
Primary completion
Jul 15, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Sep 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Cannabidiol

Start the discussion